SUPAC-MR Overlooks Mechanisms Of Release Differences - Novartis Exec
Executive Summary
Differences among sustained-release mechanisms are not sufficiently recognized in FDA's Scale-Up & Post-Approval Changes-Modified Release guidance, Novartis analytical chemist John Taylor commented during the recent Drug Information Association annual meeting in Boston.